Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Diabet Med ; 35(10): 1345-1354, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-29851428

RESUMEN

AIM: To examine the effects of diabetes, low income and their combination on mortality in the Korean population. METHODS: We analysed a total of 505 677 people (53.9% male) aged 40-79 years old from the National Health Insurance Service-National Health Screening (NHIS-HEALS) cohort. Ten levels of household income were used as indicators of economic status. Diabetes was defined as elevated fasting blood glucose (≥ 6.9 mmol/l) and/or use of glucose-lowering drugs or insulin. Covariates of age, sex, BMI, smoking and Charlson Comorbidity Index were determined at baseline. Outcomes were total and cause-specific mortality over 12 years. Cox's proportional hazard regression models were used to estimate hazard ratios (HRs) for mortality according to the presence of diabetes, household income and their combination. RESULTS: Lower household income was associated with higher mortality from all causes, cardiovascular disease, cancer and non-cancer non-cardiovascular causes. Excessive mortality due to low incomes was observed in both people with and without diabetes. In men, the adjusted HR [95% confidence interval (CI)] of mortality was 1.38 (1.34 to 1.42) for low-income only, 1.48 (1.42 to 1.55) for diabetes only and 1.95 (1.86 to 2.05) for diabetes and low-income combined, relative to the normal glucose and high income group. Corresponding HR (95% CI) in women were 1.19 (1.14 to 1.24), 1.54 (1.44 to 1.64) and 1.87 (1.75 to 2.01), respectively. CONCLUSION: Both low household income and the presence of diabetes independently increase the risk of mortality, but their combined effects on mortality may be different between men and women.


Asunto(s)
Diabetes Mellitus/economía , Diabetes Mellitus/mortalidad , Renta/estadística & datos numéricos , Adulto , Enfermedades Cardiovasculares/economía , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/mortalidad , Diabetes Mellitus/epidemiología , Angiopatías Diabéticas/economía , Angiopatías Diabéticas/epidemiología , Angiopatías Diabéticas/mortalidad , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Mortalidad , República de Corea/epidemiología , Factores de Riesgo , Factores Socioeconómicos
3.
Diabetes Metab ; 44(2): 168-171, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29395811

RESUMEN

AIMS: This study investigated the association of persistent organic pollutants (POPs), an emerging new risk factor for type 2 diabetes and the metabolic syndrome, with the presence of opposite phenotypes of glucose and lipid metabolism among normal-weight Koreans of similar body composition. METHODS: Fifty subjects, randomly selected from an ongoing community-based cohort study, from two opposite phenotype groups - metabolically unhealthy normal weight (MUHNW) and metabolically healthy normal weight (MHNW) - were matched for waist circumference, visceral fat mass and demographic variables, then compared for serum concentrations of POPs. RESULTS: Most POPs (10 out of 13 compounds) were present in higher serum concentrations in the MUHNW than in the MHNW. In particular, serum concentrations of all compounds of the organochlorine pesticide class were 2.2 to 4.7 times higher in cases than in controls. Compared with the lowest tertile of summary measures of POPs, Odds ratios (95% confidence interval) for the second and third tertiles were 7.4 (1.9-29.4) and 10.4 (2.6-41.2), respectively. Adjusting for possible confounders did not change the results. CONCLUSION: Taken altogether, these findings from the present and previous studies suggest that increased serum POP concentrations may play an important role in the development of unhealthy metabolic phenotypes in lean people.


Asunto(s)
Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/epidemiología , Contaminantes Ambientales/sangre , Síndrome Metabólico/sangre , Síndrome Metabólico/epidemiología , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Peso Corporal Ideal/fisiología , Masculino , Fenotipo , República de Corea/epidemiología , Factores de Riesgo
4.
Diabet Med ; 34(9): 1235-1243, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28523719

RESUMEN

AIM: To compare the risks of cardiovascular disease (CVD) and all-cause mortality associated with sulfonylurea (SU), dipeptidyl peptidase-4 inhibitor (DPP4i) and thiazolidinedione (TZD) as add-on medications to metformin (MET) therapy in people with Type 2 diabetes. METHODS: We identified 40 263 individuals who used SU (n = 11 582), DPP4i (n = 26 623) or TZD (n = 2058) in addition to MET between January 2013 and June 2015 from the database of the Korean National Health Insurance, the single-payer healthcare system in South Korea. Cox proportional hazard models were used to estimate hazard ratios for major CVD event (coronary artery disease, heart failure, stroke or transient ischaemic attack) development and all-cause mortality by second-line anti-diabetes medication type. Age, sex, duration of MET monotherapy, calendar year and comorbid conditions were adjusted as potential confounders. RESULTS: The observed numbers of CVD events (total observed person-time) were 485 (18 778 person-years) for MET + SU, 744 (40 374 person-years) for MET + DPP4i and 60 (3014 person-years) for MET + TZD users. Compared with MET + SU users, the fully adjusted hazard ratios for CVD events were 0.79 [95% confidence interval (CI): 0.71-0.89] for MET + DPP4i users and 0.85 (95% CI: 0.65-1.11) for MET + TZD users. The corresponding hazard ratios for all-cause mortality were 0.84 (95% CI: 0.66-1.07) for MET + DPP4i users and 0.67 (95% CI: 0.35-1.28) for MET + TZD users. CONCLUSION: Analysis of Korea National Health Insurance database showed that MET + DPP4i treatment for diabetes had a lower CVD risk than MET + SU treatment.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/epidemiología , Hipoglucemiantes/clasificación , Hipoglucemiantes/uso terapéutico , Adulto , Anciano , Inhibidores de la Dipeptidil-Peptidasa IV/uso terapéutico , Quimioterapia Combinada/clasificación , Quimioterapia Combinada/estadística & datos numéricos , Femenino , Humanos , Masculino , Metformina/uso terapéutico , Persona de Mediana Edad , República de Corea/epidemiología , Factores de Riesgo , Compuestos de Sulfonilurea/uso terapéutico , Análisis de Supervivencia , Tiazolidinedionas/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento
6.
J Nutr Sci Vitaminol (Tokyo) ; 36(4): 411-21, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2081982

RESUMEN

The oxidation products of both types of mixtures of alpha-tocopherol (alpha-Toc) and gamma-tocopherol (gamma-Toc) or alpha-Toc and delta-tocopherol (delta-Toc) during autoxidation of methyl linoleate were isolated and identified. The structures of the oxidation products were characterized by UV, IR, 1H and 13CNMR, and mass spectrometry. The 5-[2-(alpha-tocopherol-5'-yl)ethyl]-alpha-tocopherylquinone, 5-[2-(alpha-tocopherol-5'-yl)ethyl]-8a-hydroxy-alpha-tocopherone, O-[8-(5-ethoxymethyl-7-methyltocol)methyl]-alpha-tocopherol were obtained from both types of the mixtures as the oxidation products derived from alpha-Toc. gamma-Toc diphenyl ether dimer (gamma-TED) and gamma-Toc biphenyl dimer (gamma-TBD) were identified from the mixture of alpha-Toc and gamma-Toc, and delta-Toc diphenyl ether dimer (delta-TED) from the mixture of alpha-Toc and delta-Toc. However, no oxidation product composed of both alpha-Toc and gamma-Toc or delta-Toc was detected in oxidation products of both types of the mixtures. These results support the facts that, at first, oxidation of alpha-Toc proceeds during autoxidation of lipids and then gamma-Toc or delta-Toc decomposes after approximate consumption of alpha-Toc.


Asunto(s)
Ácidos Linoleicos/metabolismo , Vitamina E/metabolismo , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Estructura Molecular , Oxidación-Reducción , Espectrofotometría Infrarroja , Espectrofotometría Ultravioleta , Vitamina E/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA